Researchers at the University of Calgary and Alberta Health Services’ Tom Baker Cancer Centre are examining the potential use of the reovirus as a possible treatment for multiple myeloma–a cancer that affects blood cells. “The virus appears not to affect healthy cells, unlike radiation and chemotherapy,” says Dr. Don Morris, lead author of the study, AHS medical oncologist and member of the university’s Southern Alberta Cancer Research Institute. “In the future, this treatment might be used in conjunction with other cancer therapies, as we have recently found that the combination of reovirus and other new therapies currently used in the treatment of myeloma work better together than individually.” Read more here.
Study mentioned: Thirukkumaran CM, et al. Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma. Clin Cancer Res. 2012 Aug 3. [Epub ahead of print] PMID: 22761466
No comments:
Post a Comment